4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000103
SVP & Chief Accounting Officer sold 884 shares at $480.95 ($425,160)
- SVP & Chief Accounting Officer gave up 828 shares (to pay taxes)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Ambrose Kristen · SVP & Chief Accounting Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-02-24 | Shares withheld for taxes : show line 1 in the form 10b5-1 | −828 | $483.28 | $400,156 | 9,970 | D |
| 2025-02-25 | Sale : show line 2 in the form 10b5-1 | −884 | $480.95 | $425,160 | 9,086 | D |
| Open-market sales · 884 sh · avg $480.95 · $425,160 | ||||||
Loading xslF345X05/wk-form4_1740603976.xml…